No mourning for the conventional antipsychotics: the dawn of the atypical agents
- PMID: 9972392
- DOI: 10.1345/aph.18323
No mourning for the conventional antipsychotics: the dawn of the atypical agents
Abstract
As Markowitz et al. explain, the atypical antipsychotics should become the first-line agents for the treatment of schizophrenia. There is much to be learned about these drugs, but their displacement of the conventional antipsychotics will be a continuous process. The loss of the older drugs will not be mourned.
Comment on
-
Atypical antipsychotics. Part I: Pharmacology, pharmacokinetics, and efficacy.Ann Pharmacother. 1999 Jan;33(1):73-85. doi: 10.1345/aph.17215. Ann Pharmacother. 1999. PMID: 9972387 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
